Pharma French Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 6.56 M
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 1.33 Cr
- Revenue Growth -88.39%
- Profit Growth -480.41%
- Ebitda -152.08%
- Net Worth -41.58%
- Total Assets -76.38%
About Pharma French Pharmaceuticals India
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232TZ2006PTC012930
-
Company No.
012930
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jul 2006
-
Date of AGM
27 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Pharma French Pharmaceuticals India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deva Manivannan
|
Director | 14-Jul-2006 | Current |
|
Selvaramu Kasi
|
Director | 14-Jul-2006 | Current |
Financial Performance of Pharma French Pharmaceuticals India.
Pharma French Pharmaceuticals India Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 88.39% decrease. The company also saw a substantial fall in profitability, with a 480.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma French Pharmaceuticals India?
In 2018, Pharma French Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bestcare Formulations Private LimitedDeva Manivannan and Selvaramu Kasi are mutual person
-
Pharmafrench Private Limited
Selvaramu Kasi is a mutual person
Charges (Loans)
₹0
₹13.30 M
Charges Breakdown by Lending Institutions
- The Karur Vysya Bank Limited : 1.33 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jan 2007 | The Karur Vysya Bank Limited | ₹1.33 Cr | Satisfied |
How Many Employees Work at Pharma French Pharmaceuticals India?
Unlock and access historical data on people associated with Pharma French Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma French Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma French Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.